Microalbuminuria:A Marker for Cardiovascular Risk in Hypertensive Patients


  • Punjab Institute of Medical Sciences, Jalandhar, India


Hypertension is one of the most common diseases of the modern world. In hypertensive patients, Microalbuminuria, defined as albumin excretion rate (AER) of 30-300 mg/day or 30 - 299 mg/gm of creatinine, acts as a specific marker to detect early arterial disease&renal damage. Detection of microalbuminuria in hypertensive patients and their treatment can significantly alter the disease progression.


Microalbuminuria, Cardiovascular Risk, Hypertension.

Subject Discipline


Full Text:


Parving HH. Microalbuminuria in essential hypertension and diabetes mellitus. J Hypertens Suppl 1996 Sep; 14(2): S89-93; discussion S93-4.

Montalescot G, Collet JP. Preserving cardiac function in the hypertensive patient: Why renal parameters hold the key. Eur Heart J 2005;26:26162622.

Pontremoli R, Leoncini G, Ravera M, Viazzi F, Vettoretti S, Ratto E et al. Microalbuminuria, cardiovascular and renal risk in primary hypertension. JASN 2002 Nov; 13 Suppl 3:S169-172.

Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: The Heart Outcomes Prevention Evaluation Study Investigators. N Eng J Med 2000; 342:145-53.


  • There are currently no refbacks.